top of page

ImYoo partners with Illumina Accelerator to develop technology and launch immune studies

ImYoo was selected as part of a global cohort as part 13th funding cycle of Illumina Accelerator in the San Francisco Bay Area. Read the official press release at

7 views0 comments

Recent Posts

See All

ImYoo has partnered with Jumpcode Genomics to use Jumpcode’s RNA depletion technology to improve data quality and eliminate the uninformative sequences that were reduce the ability to gather valuable

bottom of page